T2 Biosystems, Inc.·4

Mar 18, 4:46 PM ET

Pare Anthony 4

4 · T2 Biosystems, Inc. · Filed Mar 18, 2020

Insider Transaction Report

Form 4
Period: 2020-03-14
Pare Anthony
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-03-14+105,000105,000 total
    Exercise: $0.40Exp: 2030-03-14Common Stock (105,000 underlying)
  • Award

    Restricted Stock Units

    2020-03-14+52,50052,500 total
    Common Stock (52,500 underlying)
Footnotes (3)
  • [F1]The stock option vests in 48 equal monthly installments commencing March 14, 2020.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F3]The restricted stock units vest in three equal annual installments commencing March 14, 2021.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION